Viewing nowEsomeprazole Magnesium Trihydrate 40 mg (Xmezol)
Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

MFDS item code 201404633 · Approved 2014.10.08 · Insurance code 642403910
Treatment and prevention of reflux and excess stomach acid, gastrointestinal side effects of anti-inflammatory analgesics, ulcers, and Helicobacter pylori infection; prevention of rebleeding
This medication is primarily used for the treatment and prevention of relapse in gastroesophageal reflux disease and erosive esophagitis. It is also effective in the treatment and prevention of duodenal ulcers and peptic ulcers caused by Helicobacter pylori. It helps prevent gastric and duodenal ulcers associated with gastrointestinal symptoms that may occur when using non-steroidal anti-inflammatory drugs. It is also used for the treatment of Zollinger-Ellison syndrome and for maintenance therapy to prevent rebleeding of gastric or duodenal ulcers. In summary, this medication is broadly used for the treatment and prevention of gastric and esophageal-related ulcers and inflammatory diseases.
This medicine should be swallowed with a liquid such as water; do not chew or crush it. Adults Gastroesophageal reflux disease (GERD) Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist may take it for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent episodes may be controlled by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling ongoing symptoms in patients at high risk of developing gastric and duodenal ulcers due to use of nonsteroidal anti-inflammatory drugs. Antibiotic combination therapy for eradication of Helicobacter pylori: Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg 2 times daily for 7 days. Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug (nonselective or selective COX-2) use: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials lasting longer than 4 weeks have not been conducted. Patients requiring continuous nonsteroidal anti-inflammatory drug treatment Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. Treatment of Zollinger-Ellison syndrome: The recommended initial dose is 40 mg 2 times daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into 2 doses. Maintenance therapy following initiation of intravenous treatment to prevent rebleeding due to gastric or duodenal ulcers: Administer 40 mg once daily for 4 weeks following intravenous treatment to prevent rebleeding due to gastric or duodenal ulcers. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal impairment. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. Elderly patients: No dose adjustment is necessary.
Adolescents aged 12 years and older - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist may take it for an additional 4 weeks. Adolescents aged 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents aged 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent episodes may be controlled by administering 20 mg once daily. Children under 12 years of age: There is no experience with administration of this medicine to children under 12 years of age.
This medication should not be administered to certain patients. For example, patients with hypersensitivity to this medication, its components, or benzimidazole derivatives, or those with a history of such reactions, should not use it. Additionally, when used in combination with amoxicillin or clarithromycin for the eradication of Helicobacter pylori, patients with hypersensitivity to penicillin or macrolide antibiotics should not be treated. It is also safe to avoid this medication for patients on specific heart-related drugs, antiviral medications, and lactating women. Various adverse reactions may occur during the use of this medication. Common symptoms include headache, abdominal pain, diarrhea, constipation, and nausea; rare occurrences may include blood abnormalities, liver function abnormalities, skin rashes, and myalgia. Particularly with long-term use, electrolyte abnormalities such as hypomagnesemia may occur, necessitating regular monitoring. This medication suppresses gastric acid secretion and lowers the acidity in the stomach, which may increase the risk of bacterial infections in the gastrointestinal tract, so if diarrhea persists, consult a physician. Moreover, there may be an increased risk of fractures with long-term use, so caution is advised for patients at risk for osteoporosis. This medication is prone to interactions with other drugs that can alter blood concentrations or cause side effects depending on the types of drugs taken concurrently; thus, consultation with a healthcare professional is essential. Due to limited safety data for this medication during pregnancy, it should be administered carefully when necessary, and it is recommended not to take it while breastfeeding. In case of overdose, special antidotes are not available, so treatment must be symptomatic and general care needed, and it should be stored out of reach of children. Transferring this medication to another container may adversely affect its quality, so caution should be exercised.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, dysgeusia, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized pustular psoriasis, drug reactions with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reactions, back pain, chest pain, sternal pain, facial swelling, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, rigidity, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, constipation exacerbation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased plasma gastrin, tongue disorders, tongue edema, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, joint disorders, convulsions, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, loss of appetite, apathy, increased appetite, confusion, worsening depression, hypertonicity, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, abnormal olfaction, loss of taste, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urination frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp or nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis, myalgia, asthenia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should be maintained between 1 and 30 degrees Celsius room temperature. This will help to maintain the efficacy of the medication for a longer time.
Pink round film-coated tablet
28 tablets ((14 tablets/Alu-Alu PTP*2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.